Skip to main content
Total HealthSupply
Solu-Medrol® 125 mg / 2 mL (Methylprednisolone Sodium Succinate) Act-O-Vial®
Available to order

Solu-Medrol® 125 mg / 2 mL (Methylprednisolone Sodium Succinate) Act-O-Vial®

SKU PFI 00009004722

$475.00

Packaging: 25 Vials per Carton. Confirm the selling unit with customer care before ordering if unclear.

Purchase options

Request quote
Brand
Pfizer Injectables

Categories

Product details

Product Specifications

Specification Details
Manufacturer / Brand Pfizer Pharmaceuticals / Solu-Medrol®
Manufacturer # / SKU 00009004722
NDC Number 00009-0047-22
Active Ingredient Methylprednisolone Sodium Succinate
Strength 125 mg / 2 mL
Formulation Preservative-Free, Sterile Powder for Injection
Container Type Act-O-Vial® (Dual-Chamber Vial)
Route of Admin IV (Intravenous) or IM (Intramuscular)
Packaging 25 Vials per Carton
Storage Controlled Room Temperature (20°C to 25°C)

Key Features

  • Act-O-Vial® System: Simplifies the reconstitution process; simply press down on the plastic activator to mix the diluent with the powder, eliminating the need for separate vials and syringes for mixing.

  • Rapid Anti-Inflammatory Action: Highly soluble ester provides immediate onset of action, critical for treating life-threatening allergic or inflammatory episodes.

  • Preservative-Free: Suitable for patients with sensitivities to common preservatives like benzyl alcohol (though check specific labeling for pediatric use).

  • Versatile Delivery: Can be administered via IV injection, IV infusion, or IM injection depending on the clinical urgency and patient condition.

  • Precision Dosing: The 125 mg/2 mL strength is optimized for standard adult doses and pediatric weight-based protocols.

Clinical Applications

  • Acute Exacerbations: Treatment of acute flares in Multiple Sclerosis or Rheumatic disorders.

  • Severe Allergic Reactions: Management of anaphylaxis, status asthmaticus, or drug hypersensitivity.

  • Critical Care: Adjunctive therapy in certain life-threatening conditions or shock.

  • Dermatologic Conditions: Treatment of severe erythema multiforme (Stevens-Johnson syndrome).

⚠️ Reconstitution Note: Use the solution within 48 hours after mixing. The reconstituted solution should be clear; do not use if it is cloudy or contains particulates.

⚠️ Safety Alert: Not for use by the intrathecal route of administration. Monitor for hypertension, sodium retention, and potential psychiatric disturbances during therapy.

⚠️ Contraindications: Contraindicated in patients with systemic fungal infections or known hypersensitivity to methylprednisolone.

Solu-Medrol® 125 mg / 2 mL (Methylprednisolone Sodium Succinate) Act-O-Vial® · Total Health Supply